On October 18, 2017, Dr. Yin Chen, associate professor of Department of Pharmacology and Toxicology, University of Arizona, at the invitation of Prof. Long Chen from Biochemistry and Biological Product Institute of Nanjing Normal University College of Life Sciences, came to our college for academic exchange. Dr. Chen gave a talk entitled “Airway innate immunity: pathogens and novel therapies” at 10:00 am on October 18.
Dr. Chen brought three interesting “stories” to teachers and students around three directions: asthma, chronic obstructive pulmonary disease (COPD), and anti-cancer drugs. Dr. Chen started his speech firstly by introducing the difference between asthma and allergies and the source of asthma, and then specially introduced the protective role of type I interferon in asthma induced by fungi and other factors. On the part of the chronic obstructive pulmonary disease, Dr. Chen found that the more serious the COPD patients are, the less CC16 protein in their body, and identified that CC16 protein has a good protective effect on the lungs. It can be used for treating the chronic bronchitis caused by smoking. In the anti-cancer drug, Dr. Chen and his team focus on small molecule active polypeptide, which is remarkable for the cancer effect, For example, MPS-3080 can not only inhibit cancer cells but also further enhance the effect of first-line anticancer drugs. In the report, Dr. Chen had in-depth academic exchanges with the attending teachers and students on related issues and let the teachers and students who listen to the report had great inspiration. After the report, Dr. Chen also conducted deep exchanges for a possible relative cooperation with Prof. Long Chen’s group in the future.